DD-Financial and Company Info through 2014 Q3

New Post Public Reply Private Reply Replies (0) Message Board
H.E. Pennypacker
DD-Financial and Company Info through 2014 Q3

For new investors, or anyone here who hasn't completely looked 'under the hood' yet, here’s a retrospective on $STEV’s fins so far this year for DD and projection purposes. Also, included are pertinent company notes for $STEV.

These are the financial numbers and info we have to date (2014 Calendar year) (See below for fiscal year):

Revenue:
Q1 2014 - $4,479,334
-Revenue source - Stevia harvest (Feb/March 2014)


Q2 2014 - $2,217,026
-Revenue source - Stevia harvest (Feb/March 2014)


Q3 2014 - $514,958
-Revenue source - $200,000+ order to Darden from Aquaculture


Q4 2014 - ?????
-Revenue source - Hemp harvest (Oct- Dec) w/commercial orders lined up. Would love updates on yield, sales, etc.


2014 calendar year to date (Q1+Q2+Q3) revenues = $7,211,318

2013 calendar year total revenues (Q1+Q2+Q3+Q4) = $2,168,093



Keep in mind STEV's fiscal year ends 3/31, and Q2 is the first quarter of the new fiscal year. So we have seen two quarters of STEV’s fiscal year:

Q1 2013 - $957,261
Q2 2014 - $2,217,026 (up $1.35M) (130% increase)

Q2 2013 – $547,858
Q2 2014 – $514,958

Q3 2013 – $388,746
Q3 2014 –

Q4 2013 - $4,479,334
Q4 2014 -

2013 Fiscal (Ended 3/31/14) – $6,373,199
2014 Fiscal (Ends 3/31/15) - $2,731,984 (was $1,495,119 at this point in 2013)



Quick financial notes from the Q1 2014 (largest revenue quarter in $STEV company history, as the company reported a record harvest):
Link: http://archive.fast-edgar.com//20140819/APK2H...A4Y823262/

1. Total assets up over 20% to $5.48M, including over $3M in prepaid seeds and fertilizer.

2. Total current liabilities down over from $1.3M to $913K

3. Total liabilities down from $6.74M to $2.4M

4. Total equity up from -$2.35M to $3.09M

5. Revenue up from $957K to $2.2M

6. Gross margin up from -$144K to $480K

7. EPS up from -$.02 to .01


Takeaway: Assets up, current and total liabilities significantly down, equity significantly higher, revenues more than doubled. Gross margin shows the business model is making money. Revenue growth is VERY strong...AGAIN. Great quarter over quarter and year over year growth.

Moreover, the company issued a PR in November expecting 2015 harvest to outperform this and establish another record harvest... which again would mean record revenues for Q1 2015.

http://finance.yahoo.com/news/stevia-corp-tra...00284.html



Quick Company Notes:

Already purchased all the seeds/fertilizer for Spring 2015 harvest

PG. 29 of 10q:

*The company acquired certain seeds and fertilizer in the amount of $3,136,630 in aggregate which was used for preparation of the fall planting for the spring harvest which will start from the second half of February, 2015 and last through April, 2015. In Q1 and Q2 2015 operating (farm) expenses will be significantly lower! This expense has already been paid for and $STEV still showed a positive gross margin and earnings per share!



STEV's biggest quarter every year is their fiscal Q4 (Jan1 - March 31) because of the stevia harvest. In 2014 over $4M in revs.



Diverse and vertical integration: Aquaculture, feed for livestock, fertilizers, commercial growing ($12,000 per hectare), extraction ($60,000 per hectare), and cannabis crossover applications (CBD extraction) (see p. 6). $STEV supplies services under three business models - 1) contract farming model, 2) revenue share model and 3) product supply model.



Vietnam location (as opposed to China where 80% of Stevia is grown has huge advantages as it relates to year round production as opposed to 2 major growing seasons. (see p.8)



Competitive Advantage - intellectual property, particularly our fertilizers and feed additives and other input products used in our protocols, have the potential to create a dedicated customer base because the protocols once implemented on a farm call for continual use of our fertilizers and feed additives and other products as a mandatory production input. We believe this long-term customer relationship can enable us to create a substantial barrier to entry to potential new competitors, while at the same time providing networking benefits that could further propagate our business. (see p.12).



Prepaid expenses: Both expenses for fertilizer ($1.5M) and leased farmland (Through 2014) have been prepaid for the next few quarters. Should help future margins.



Excellent O/S structure going forward – 197M O/S is a very workable share structure. (Caution: see note below – ‘negative risk factor’ – as $STEV is currently seeking more financing to continue operations). This share amount has remained steady for the last several months, as per TA.



Executive compensation – CEO Blankenbaker gets $213k reported income… but the compensation is share based. He receives 4M shares a year: ‘On February 26, 2014, the Company issued 20,000,000 Restricted Shares to George Blankenbaker, the Company's President and director for services to be rendered. 4,000,000 of such shares vest at the time of issuance and the remainder vest over the following four years in equal annual installments. These shares were valued at $0.053365 per share or $1,067,300 at the date of grant, $213,460 of which were recorded as salary and compensation at the time of issuance and $853,840 of which are being amortized over the vesting period of four (4) years or $213,460 annually recorded as salary and compensation - officers.’

Directors fees under the same compensation format, but at 750k shares per year, 2 year deal (1.5M total shares).



Gross Margin rising: (2012): (-$709,946), (2013): (-$449,288), (2014): $691,183 (Big move up in margin)



Future revenue from growth/extraction alone is huge – 110 hectares, potentially $72,000 per hectare between leaf harvest and extraction - potentially $7.92M per annum from this revenue line: ‘$STEV has acquired two grower supply contracts and three nursery fields in Vietnam with total propagation exceeding 100 Ha (250 acres). On December 14, 2011 we entered into a land lease agreement with Stevia Ventures Corporation, whereby Stevia Ventures Corporation leased 10 Ha (25 acres) of land over 5 years.’ (see p.13)

See December 22 PR re: Synthetic CBD expansion through $STEV subsidiary SteviaTechnew: http://finance.yahoo.com/news/stevia-corp-con...18339.html



Negative/Risk factors: Expect more notes, and potentially more dilution in the next few months, IMO: ‘We do not expect that our revenues from operations will be wholly sufficient to fund our operating plan, so we are currently seeking further financing and we believe that, along with our revenues, will provide sufficient working capital to fund our operations for at least the next six months. Changes in our operating plans, increased expenses, acquisitions, or other events, may cause us to seek additional equity or debt financing in the future.’ (see p.39 of annual)


Takeaway:
Bullish. $STEV has a positive P/E ratio of .01 and rapidly rising revenues squarely based in in stevia harvest and sales alone. With more revenue streams in emerging markets (CBD/Hemp, Aquaculture) coming online/growing in 2015 to move well up from current prices in 2015.

Stevia Corp. (STEV) Stock Research Links

STEV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading